Showing 1 - 10 of 191,451
IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and …
Persistent link: https://www.econbiz.de/10012829465
Persistent link: https://www.econbiz.de/10011740137
The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge … norms that are considered legitimated to carry out innovation in the biotech field. …
Persistent link: https://www.econbiz.de/10014370414
Persistent link: https://www.econbiz.de/10012264996
Persistent link: https://www.econbiz.de/10012116537
Persistent link: https://www.econbiz.de/10011821340
We estimate the effects of a simplification in the bureaucratic regulation for doing business on firm demographics in Italy, where a 2011 legislation reform required all municipalities to institute a one-stop shop for doing business. We use data for all Italian firms active in private...
Persistent link: https://www.econbiz.de/10012999587
discontinuity design, this dissertation provides some first causal evidence of the effect of occupational deregulation on the self …
Persistent link: https://www.econbiz.de/10013419315
"This book specifically provides the reader with the methodologies necessary to create a successful life sciences start-up from initiation to exit. The readers gain an appreciation for the necessary data, partnership, and skills to be acquired and the constituencies that must be satisfied, along...
Persistent link: https://www.econbiz.de/10010466371
specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong … appropriabilty regime the optimal strategy is to license the innovation to an incumbent product firm. This paper argues by contrast … commercialize alone or to pursue a hybrid arrangement (called co-promotion) whereby it licenses the innovation but retains the …
Persistent link: https://www.econbiz.de/10010357556